These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30681958)

  • 1. The Experience of the Treatment Demand Indicator in Europe: A Common Monitoring Tool Across 30 Countries.
    Montanari L; Pirona A; Guarita B; Hedrich D; Mounteney J; Vicente J
    J Stud Alcohol Drugs Suppl; 2019 Jan; Sup 18(18):139-151. PubMed ID: 30681958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EMCDDA/Pompidou Group treatment demand indicator protocol: a European core item set for treatment monitoring and reporting.
    Simon R; Donmall M; Hartnoll R; Kokkevi A; Ouwehand AW; Stauffacher M; Vicente J
    Eur Addict Res; 1999 Dec; 5(4):197-207. PubMed ID: 10705187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis Use among People Entering Drug Treatment in Europe: A Growing Phenomenon?
    Montanari L; Guarita B; Mounteney J; Zipfel N; Simon R
    Eur Addict Res; 2017; 23(3):113-121. PubMed ID: 28511182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends of heroin use and heroin injection epidemics in Europe: findings from the EMCDDA treatment demand indicator (TDI).
    Barrio G; Montanari L; Bravo MJ; Guarita B; de la Fuente L; Pulido J; Vicente J
    J Subst Abuse Treat; 2013 Jul; 45(1):19-30. PubMed ID: 23462151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015.
    Mounteney J; Griffiths P; Sedefov R; Noor A; Vicente J; Simon R
    Addiction; 2016 Jan; 111(1):34-48. PubMed ID: 26419329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent trends in drug treatment in Europe.
    Kinnunen A; Nilson M
    Eur Addict Res; 1999 Sep; 5(3):145-52. PubMed ID: 10460979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug treatment in the Baltic countries.
    Subata E
    Eur Addict Res; 1999 Sep; 5(3):138-44. PubMed ID: 10460978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observations on the recent history of drug user counseling.
    Brown BS
    Int J Addict; 1993 Oct; 28(12):1243-55. PubMed ID: 8282452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An organizational analysis of service patterns in outpatient drug abuse treatment units.
    D'Aunno T; Vaughn TE
    J Subst Abuse; 1995; 7(1):27-42. PubMed ID: 7655310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American Indians with substance use disorders: treatment needs and comorbid conditions.
    Rieckmann T; McCarty D; Kovas A; Spicer P; Bray J; Gilbert S; Mercer J
    Am J Drug Alcohol Abuse; 2012 Sep; 38(5):498-504. PubMed ID: 22931085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Relationship Between Client Characteristics and Wraparound Services in Substance Use Disorder Treatment Centers.
    Paino M; Aletraris L; Roman P
    J Stud Alcohol Drugs; 2016 Jan; 77(1):160-9. PubMed ID: 26751366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Needs-Based Planning Model to Estimate Required Capacity of a Substance Use Treatment System.
    Rush B; Tremblay J; Brown D
    J Stud Alcohol Drugs Suppl; 2019 Jan; Sup 18(18):51-63. PubMed ID: 30681949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic cannabinoid withdrawal: a new demand on detoxification services.
    Macfarlane V; Christie G
    Drug Alcohol Rev; 2015 Mar; 34(2):147-53. PubMed ID: 25588420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results from the 4th National Clients of Treatment Service Agencies census: changes in clients' substance use and other characteristics.
    Shand F; Mattick RP
    Aust N Z J Public Health; 2002 Aug; 26(4):352-7. PubMed ID: 12233957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing pattern of drug abuse among patients entering treatment in Lazio, Italy, between 1996 and 2003: transition from heroin to cocaine use.
    Davoli M; Pasqualini F; Belleudi V; Bargagli AM; Perucci CA
    Eur Addict Res; 2007; 13(4):185-91. PubMed ID: 17851239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A profile of alcohol and drug clients in New Zealand: results from the 1998 national telephone survey.
    Adamson SJ; Sellman JD; Futterman-Collier A; Huriwai T; Deering D; Todd F; Robertson P
    N Z Med J; 2000 Oct; 113(1119):414-6. PubMed ID: 11127357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute recreational drug and new psychoactive substance toxicity in Europe: 12 months data collection from the European Drug Emergencies Network (Euro-DEN).
    Dines AM; Wood DM; Yates C; Heyerdahl F; Hovda KE; Giraudon I; Sedefov R; Dargan PI;
    Clin Toxicol (Phila); 2015 Nov; 53(9):893-900. PubMed ID: 26503789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The German monitoring and reporting system for the treatment of substance-related problems: a national system on the basis of aggregated data.
    Simon R; Hoch E; Holz A
    Eur Addict Res; 1999 Dec; 5(4):167-72. PubMed ID: 10705182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sobering-up stations in the Czech Republic in the context of analogous models of care for acute intoxications in Europe].
    Mravčík V; Burešová Z; Popov P; Miovský M
    Cas Lek Cesk; 2013; 152(3):129-34. PubMed ID: 23822545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Pompidou Group treatment demand protocol: the first pan-European standard in the field.
    Stauffacher M; Kokkevi A
    Eur Addict Res; 1999 Dec; 5(4):191-6. PubMed ID: 10705186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.